ArticleEuropean heart journal2026

Genetic variants of glucose-dependent insulinotropic polypeptide (GIP) signalling as proxy for body weight reduction and cardiovascular risk.

Frida Emanuelsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.